SCHEMBL489366

SCHEMBL489366

C=CC(=O)OCCOCCOCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.61
ALDH1A1 P00352 5/20 0.61
TP53 P04637 2/20 0.61
HIF1A Q16665 2/20 0.61
HSD17B10 Q99714 1/20 0.61
THRB P10828 2/20 0.59
TEAD3 Q99594 2/20 0.49
HCAR2 Q8TDS4 2/20 0.47
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
AKR1B10 O60218 3/20 0.45
AKR1B1 P15121 3/20 0.45
MAOB P27338 1/20 0.44
CYP3A4 P08684 1/20 0.43
NAAA Q02083 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22166136 1.00 TSHR (0.61) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL318098 0.98 THRB (0.61) TSHRALDH1A1TP53HIF1AHSD17B10
Ethylene Glycol SCHEMBL1087639 0.89 THRB (0.58) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL489015 0.89 TEAD3 (0.54) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL9164139 0.89 TSHR (0.63) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL17439437 0.86 ALDH1A1 (0.59) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL12680096 0.86 THRB (0.51) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL31453304 0.84 HCAR2 (0.59) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL13899402 0.84 THRB (0.59) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL15307664 0.83 THRB (0.50) TSHRALDH1A1TP53HIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260003210-A1 DIFFRACTIVE CONTACT LENSES ALCON INC (CH) 2026-01-01 US claimed
US-12379611-B2 Diffractive contact lenses ALCON INC. (CH) 2025-08-05 US claimed
EP-4121802-B1 HIGH REFRACTIVE INDEX SILOXANE INSERT MATERIALS FOR EMBEDDED CONTACT LENSES ALCON INC (CH) 2024-07-17 EP claimed
US-20240142665-A1 OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2024-05-02 US claimed
EP-4356169-A1 MULTIFOCAL DIFFRACTIVE SILICONE HYDROGEL CONTACT LENSES Alcon Inc. (CH) 2024-04-24 EP claimed
US-20240117092-A1 OPTICALLY ACTIVE DEVICES AMO Ireland (IE) 2024-04-11 US claimed
CN-117280252-A Multifocal diffractive silicone hydrogel contact lenses 爱尔康公司 2023-12-22 CN claimed
EP-4284787-A1 OPTICALLY ACTIVE DEVICES AMO Ireland (IE) 2023-12-06 EP claimed
EP-4263513-A1 OPTICALLY ACTIVE DEVICES AMO Ireland (IE) 2023-10-25 EP claimed
US-11618823-B2 High refractive index siloxane insert materials for embedded contact lenses ALCON INC. (CH) 2023-04-04 US claimed
US-20090093603-A1 OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS ALCON, INC. (CH) 2009-04-09 US claimed
WO-2009046045-A1 OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS CONTAINING AN ALKYL ETHOXYLATE ALCON, INC. (CH) 2009-04-09 WO claimed
WO-2009046055-A1 OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS CONTAINING AN ALKYLPHENOL ETHOXYLATE ALCON, INC. (CH) 2009-04-09 WO claimed
US-20090093604-A1 OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS ALCON, INC. (CH) 2009-04-09 US claimed
WO-2009046235-A1 OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS ALCON, INC. (CH) 2009-04-09 WO claimed
WO-2009046243-A1 OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS ALCON, INC. (CH) 2009-04-09 WO claimed
WO-2009046232-A1 OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS ALCON, INC. (CH) 2009-04-09 WO claimed
US-20090093592-A1 OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS ALCON, INC. (CH) 2009-04-09 US claimed
US-20090088544-A1 OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS CONTAINING AN ALKYL ETHOXYLATE ALCON, INC. (CH) 2009-04-02 US claimed
US-20090088493-A1 OPHTHALMIC AND OTORHINOLARYNGOLOGICAL DEVICE MATERIALS CONTAINING AN ALKYLPHENOL ETHOXYLATE ALCON, INC. (CH) 2009-04-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260003210-A1 DIFFRACTIVE CONTACT LENSES LBR, CRYZ, CRYAA TSHR 1437/4885ALDH1A1 1323/4885TP53 1115/4885
US-20240117092-A1 OPTICALLY ACTIVE DEVICES PDE6C, UACA, PDE6A TSHR 4604/4885ALDH1A1 538/4885TP53 4769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.